Projects must be focused on making an impact on human health- and/or life-span by targeting the ageing process directly, or by targeting age-related diseases. Age-related diseases include cardiovascular disease, cancer, and neurodegenerative diseases. Projects with the potential of leading to new therapeutics, interventions, diagnostics, and biomarkers will be prioritised.